Literature DB >> 20428221

Radiotherapy: Secondary malignancies after prostate cancer treatment.

Judd W Moul.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20428221     DOI: 10.1038/nrclinonc.2010.59

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

1.  Profit and questions as doctors offer prostate cancer therapy.

Authors:  Stephanie Saul
Journal:  N Y Times Web       Date:  2006-12-01

Review 2.  Clinical practice. Localized prostate cancer.

Authors:  Patrick C Walsh; Theodore L DeWeese; Mario A Eisenberger
Journal:  N Engl J Med       Date:  2007-12-27       Impact factor: 91.245

Review 3.  ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate.

Authors:  Jeff M Michalski; Mack Roach; Gregory Merrick; Mitchell S Anscher; David C Beyer; Colleen A Lawton; W Robert Lee; Alan Pollack; Seth A Rosenthal; Srinivasan Vijayakumar; Peter R Carroll
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-04-20       Impact factor: 7.038

4.  Postoperative radiotherapy of the prostate for patients undergoing radical prostatectomy with positive margins, seminal vesicle involvement and/or penetration through the capsule.

Authors:  D F Paulson; J W Moul; J E Robertson; P J Walther
Journal:  J Urol       Date:  1990-06       Impact factor: 7.450

5.  Radical surgery versus radiotherapy for adenocarcinoma of the prostate.

Authors:  D F Paulson; G H Lin; W Hinshaw; S Stephani
Journal:  J Urol       Date:  1982-09       Impact factor: 7.450

6.  The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients.

Authors:  Naeem Bhojani; Umberto Capitanio; Nazareno Suardi; Claudio Jeldres; Hendrik Isbarn; Shahrokh F Shariat; Markus Graefen; Philippe Arjane; Alain Duclos; Jean-Baptiste Lattouf; Fred Saad; Luc Valiquette; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-02-01       Impact factor: 7.038

7.  Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.

Authors:  F J Fowler; M McNaughton Collins; P C Albertsen; A Zietman; D B Elliott; M J Barry
Journal:  JAMA       Date:  2000-06-28       Impact factor: 56.272

8.  Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement and/or penetration through the capsule.

Authors:  M S Anscher; L R Prosnitz
Journal:  J Urol       Date:  1987-12       Impact factor: 7.450

Review 9.  Open radical retropubic prostatectomy 2007: the true minimally invasive surgery for localized prostate cancer?

Authors:  Israel P Nosnik; Tong J Gan; Judd W Moul
Journal:  Expert Rev Anticancer Ther       Date:  2007-09       Impact factor: 4.512

Review 10.  Prostate cancer: the new landscape.

Authors:  Judd W Moul; Vladimir Mouraviev; Leon Sun; Florian R Schroeck; Thomas J Polascik
Journal:  Curr Opin Urol       Date:  2009-03       Impact factor: 2.309

  10 in total
  4 in total

1.  Perspectives on the role of breast cancer susceptibility gene in breast cancer.

Authors:  Nan Wu; Lijuan Wei; Lijuan Li; Fangxuan Li; Jinpu Yu; Juntian Liu
Journal:  Int J Clin Oncol       Date:  2022-01-22       Impact factor: 3.402

2.  The value of FATS expression in predicting sensitivity to radiotherapy in breast cancer.

Authors:  Jun Zhang; Nan Wu; Tiemei Zhang; Tao Sun; Yi Su; Jing Zhao; Kun Mu; Zhao Jin; Ming Gao; Juntian Liu; Lin Gu
Journal:  Oncotarget       Date:  2017-06-13

Review 3.  Cancer risk assessment in modern radiotherapy workflow with medical big data.

Authors:  Fu Jin; Huan-Li Luo; Juan Zhou; Ya-Nan He; Xian-Feng Liu; Ming-Song Zhong; Han Yang; Chao Li; Qi-Cheng Li; Xia Huang; Xiu-Mei Tian; Da Qiu; Guang-Lei He; Li Yin; Ying Wang
Journal:  Cancer Manag Res       Date:  2018-06-22       Impact factor: 3.989

4.  Oxygen-Enriched Metal-Phenolic X-Ray Nanoprocessor for Cancer Radio-Radiodynamic Therapy in Combination with Checkpoint Blockade Immunotherapy.

Authors:  Wei Sang; Lisi Xie; Guohao Wang; Jie Li; Zhan Zhang; Bei Li; Sen Guo; Chu-Xia Deng; Yunlu Dai
Journal:  Adv Sci (Weinh)       Date:  2020-12-31       Impact factor: 16.806

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.